ArticleAnti-cancer drugs2012

Vascular endothelial growth factor receptor 2 inhibition in-vivo affects tumor vasculature in a tumor type-dependent way and downregulates vascular endothelial growth factor receptor 2 protein without a prominent role for miR-296.

Elise Langenkamp et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.